Back

Tirzepatide and the prevention of heart failure in patients with obesity and atrial fibrillation: a multicenter real-world cohort study

9 May 2026 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Nutrition, obesity, and metabolism in heart failure Prevention HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Chichen Yang

Chi-Mei Medical Center, Tainan (Taiwan)

4 More presentations in this session

Presentation thumbnail
Impact of a structured outpatient nutritional intervention on nutritional status and quality of life in elderly patients with chronic heart failure: results from the BOCADOS-IC Trial
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Comprehensive evaluation of anthropometric parameters, physical and functional performance, and dietary patterns in patients with chronic heart failure: The DIET PILLARS cohort study
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
The so-called obesity paradox: real-world evidence from a national referral centre in Latin America
Doctor C. Martinez Medrano (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
The malnourished heart failure patient: the impact by ejection fraction
Doctor N. Melarkey (Newry, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Nutrition, obesity, and metabolism in heart failure

The Event

Event poster

Heart Failure 2026

9 May 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Medical treatment of obesity in heart failure
thumbnail
Congress Presentation
Preventing and treating heart failure with preserved ejection fraction in obesity: the role of pharmacological therapy
thumbnail
Congress Session
Advances in heart failure detection and therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources